The Coalition for Epidemic Preparedness Innovations is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases.
CEPI is focused on the World Health Organization's "blueprint priority diseases", which include: the Middle East respiratory syndrome-related coronavirus, the Severe acute respiratory syndrome coronavirus 2, the Nipah virus, the Lassa fever virus, and the Rift Valley fever virus, as well as the Chikungunya virus and the hypothetical, unknown pathogen "Disease X". CEPI investment also requires "equitable access" to the vaccines during outbreaks, although subsequent CEPI policy changes may have compromised this criteria.
CEPI was conceived in 2015 and formally launched in 2017 at the World Economic Forum in Davos, Switzerland. It was co-founded and co-funded with US$460 million from the Bill and Melinda Gates Foundation, the Wellcome Trust, and a consortium of nations composed of India, Germany, Japan and Norway, which the European Union and United Kingdom subsequently joined. CEPI is headquartered in Oslo, Norway.